Global Parkinsons Disease Drug Market Growth 2021-2026

Global Parkinsons Disease Drug Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Parkinsons Disease Drug Consumption 2016-2026
2.1.2 Parkinsons Disease Drug Consumption CAGR by Region
2.2 Parkinsons Disease Drug Segment by Type
2.2.1 Carbidopa/Levodopa
2.2.2 Dopamine Receptor Agonists
2.2.3 MAO-Inhibitors
2.3 Parkinsons Disease Drug Sales by Type
2.3.1 Global Parkinsons Disease Drug Sales Market Share by Type (2016-2021)
2.3.2 Global Parkinsons Disease Drug Revenue and Market Share by Type (2016-2021)
2.3.3 Global Parkinsons Disease Drug Sale Price by Type (2016-2021)
2.4 Parkinsons Disease Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Parkinsons Disease Drug Sales by Application
2.5.1 Global Parkinsons Disease Drug Sale Market Share by Application (2016-2021)
2.5.2 Global Parkinsons Disease Drug Revenue and Market Share by Application (2016-2021)
2.5.3 Global Parkinsons Disease Drug Sale Price by Application (2016-2021)

3 Global Parkinsons Disease Drug by Company
3.1 Global Parkinsons Disease Drug Sales Market Share by Company
3.1.1 Global Parkinsons Disease Drug Sales by Company (2019-2021)
3.1.2 Global Parkinsons Disease Drug Sales Market Share by Company (2019-2021)
3.2 Global Parkinsons Disease Drug Revenue Market Share by Company
3.2.1 Global Parkinsons Disease Drug Revenue by Company (2019-2021)
3.2.2 Global Parkinsons Disease Drug Revenue Market Share by Company (2019-2021)
3.3 Global Parkinsons Disease Drug Sale Price by Company
3.4 Global Manufacturers Parkinsons Disease Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Parkinsons Disease Drug Product Location Distribution
3.4.2 Players Parkinsons Disease Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Parkinsons Disease Drug by Region
4.1 Global Parkinsons Disease Drug by Region
4.1.1 Global Parkinsons Disease Drug Sales by Region
4.1.2 Global Parkinsons Disease Drug Revenue by Region
4.2 Americas Parkinsons Disease Drug Sales Growth
4.3 APAC Parkinsons Disease Drug Sales Growth
4.4 Europe Parkinsons Disease Drug Sales Growth
4.5 Middle East & Africa Parkinsons Disease Drug Sales Growth

5 Americas
5.1 Americas Parkinsons Disease Drug Sales by Country
5.1.1 Americas Parkinsons Disease Drug Sales by Country (2016-2021)
5.1.2 Americas Parkinsons Disease Drug Revenue by Country (2016-2021)
5.2 Americas Parkinsons Disease Drug Sales by Type
5.3 Americas Parkinsons Disease Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Parkinsons Disease Drug Sales by Region
6.1.1 APAC Parkinsons Disease Drug Sales by Region (2016-2021)
6.1.2 APAC Parkinsons Disease Drug Revenue by Region (2016-2021)
6.2 APAC Parkinsons Disease Drug Sales by Type
6.3 APAC Parkinsons Disease Drug Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Parkinsons Disease Drug by Country
7.1.1 Europe Parkinsons Disease Drug Sales by Country (2016-2021)
7.1.2 Europe Parkinsons Disease Drug Revenue by Country (2016-2021)
7.2 Europe Parkinsons Disease Drug Sales by Type
7.3 Europe Parkinsons Disease Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Parkinsons Disease Drug by Country
8.1.1 Middle East & Africa Parkinsons Disease Drug Sales by Country (2016-2021)
8.1.2 Middle East & Africa Parkinsons Disease Drug Revenue by Country (2016-2021)
8.2 Middle East & Africa Parkinsons Disease Drug Sales by Type
8.3 Middle East & Africa Parkinsons Disease Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Parkinsons Disease Drug Distributors
10.3 Parkinsons Disease Drug Customer

11 Global Parkinsons Disease Drug Market Forecast
11.1 Global Parkinsons Disease Drug Forecast by Region
11.1.1 Global Parkinsons Disease Drug Forecast by Regions (2021-2026)
11.2.2 Global Parkinsons Disease Drug Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Parkinsons Disease Drug Forecast by Type
11.7 Global Parkinsons Disease Drug Forecast by Application

12 Key Players Analysis
12.1 Teva
12.1.1 Teva Company Information
12.1.2 Teva Parkinsons Disease Drug Product Offered
12.1.3 Teva Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Teva Main Business Overview
12.1.5 Teva Latest Developments
12.2 Novartis AG
12.2.1 Novartis AG Company Information
12.2.2 Novartis AG Parkinsons Disease Drug Product Offered
12.2.3 Novartis AG Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis AG Main Business Overview
12.2.5 Novartis AG Latest Developments
12.3 GSK
12.3.1 GSK Company Information
12.3.2 GSK Parkinsons Disease Drug Product Offered
12.3.3 GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 GSK Main Business Overview
12.3.5 GSK Latest Developments
12.4 AbbVie
12.4.1 AbbVie Company Information
12.4.2 AbbVie Parkinsons Disease Drug Product Offered
12.4.3 AbbVie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 AbbVie Main Business Overview
12.4.5 AbbVie Latest Developments
12.5 Merck
12.5.1 Merck Company Information
12.5.2 Merck Parkinsons Disease Drug Product Offered
12.5.3 Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Merck Main Business Overview
12.5.5 Merck Latest Developments
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Information
12.6.2 Boehringer Ingelheim Parkinsons Disease Drug Product Offered
12.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Boehringer Ingelheim Main Business Overview
12.6.5 Boehringer Ingelheim Latest Developments
12.7 Impax Laboratories
12.7.1 Impax Laboratories Company Information
12.7.2 Impax Laboratories Parkinsons Disease Drug Product Offered
12.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Impax Laboratories Main Business Overview
12.7.5 Impax Laboratories Latest Developments
12.8 Lundbeck
12.8.1 Lundbeck Company Information
12.8.2 Lundbeck Parkinsons Disease Drug Product Offered
12.8.3 Lundbeck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Lundbeck Main Business Overview
12.8.5 Lundbeck Latest Developments
12.9 Sun Pharma
12.9.1 Sun Pharma Company Information
12.9.2 Sun Pharma Parkinsons Disease Drug Product Offered
12.9.3 Sun Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sun Pharma Main Business Overview
12.9.5 Sun Pharma Latest Developments
12.10 Wockhardt
12.10.1 Wockhardt Company Information
12.10.2 Wockhardt Parkinsons Disease Drug Product Offered
12.10.3 Wockhardt Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Wockhardt Main Business Overview
12.10.5 Wockhardt Latest Developments
12.11 UCB
12.11.1 UCB Company Information
12.11.2 UCB Parkinsons Disease Drug Product Offered
12.11.3 UCB Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 UCB Main Business Overview
12.11.5 UCB Latest Developments
12.12 Bausch Health
12.12.1 Bausch Health Company Information
12.12.2 Bausch Health Parkinsons Disease Drug Product Offered
12.12.3 Bausch Health Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Bausch Health Main Business Overview
12.12.5 Bausch Health Latest Developments
12.13 Acadia
12.13.1 Acadia Company Information
12.13.2 Acadia Parkinsons Disease Drug Product Offered
12.13.3 Acadia Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Acadia Main Business Overview
12.13.5 Acadia Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Parkinsons Disease Drug Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Carbidopa/Levodopa
Table 3. Major Players of Dopamine Receptor Agonists
Table 4. Major Players of MAO-Inhibitors
Table 5. Global Parkinsons Disease Drug Sales by Type (2016-2021) & (K Doses)
Table 6. Global Parkinsons Disease Drug Sales Market Share by Type (2016-2021)
Table 7. Global Parkinsons Disease Drug Revenue by Type (2016-2021) & ($ million)
Table 8. Global Parkinsons Disease Drug Revenue Market Share by Type (2016-2021)
Table 9. Global Parkinsons Disease Drug Sale Price by Type (2016-2021)
Table 10. Global Parkinsons Disease Drug Sales by Application (2016-2021) & (K Doses)
Table 11. Global Parkinsons Disease Drug Sales Market Share by Application (2016-2021)
Table 12. Global Parkinsons Disease Drug Value by Application (2016-2021)
Table 13. Global Parkinsons Disease Drug Revenue Market Share by Application (2016-2021)
Table 14. Global Parkinsons Disease Drug Sale Price by Application (2016-2021)
Table 15. Global Parkinsons Disease Drug Sales by Company (2019-2021) & (K Doses)
Table 16. Global Parkinsons Disease Drug Sales Market Share by Company (2019-2021)
Table 17. Global Parkinsons Disease Drug Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Parkinsons Disease Drug Revenue Market Share by Company (2019-2021)
Table 19. Global Parkinsons Disease Drug Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Parkinsons Disease Drug Producing Area Distribution and Sales Area
Table 21. Players Parkinsons Disease Drug Products Offered
Table 22. Parkinsons Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Parkinsons Disease Drug Sales by Region (2016-2021) (K Doses)
Table 26. Global Parkinsons Disease Drug Sales Market Share by Region (2016-2021)
Table 27. Global Parkinsons Disease Drug Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Parkinsons Disease Drug Revenue Market Share by Region (2016-2021)
Table 29. Americas Parkinsons Disease Drug Sales by Country (2016-2021) & (K Doses)
Table 30. Americas Parkinsons Disease Drug Sales Market Share by Country (2016-2021)
Table 31. Americas Parkinsons Disease Drug Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Parkinsons Disease Drug Revenue Market Share by Country (2016-2021)
Table 33. Americas Parkinsons Disease Drug Sales by Type (2016-2021) & (K Doses)
Table 34. Americas Parkinsons Disease Drug Sales Market Share by Type (2016-2021)
Table 35. Americas Parkinsons Disease Drug Sales by Application (2016-2021) & (K Doses)
Table 36. Americas Parkinsons Disease Drug Sales Market Share by Application (2016-2021)
Table 37. APAC Parkinsons Disease Drug Sales by Region (2016-2021) & (K Doses)
Table 38. APAC Parkinsons Disease Drug Sales Market Share by Region (2016-2021)
Table 39. APAC Parkinsons Disease Drug Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Parkinsons Disease Drug Revenue Market Share by Region (2016-2021)
Table 41. APAC Parkinsons Disease Drug Sales by Type (2016-2021) & (K Doses)
Table 42. APAC Parkinsons Disease Drug Sales Market Share by Type (2016-2021)
Table 43. APAC Parkinsons Disease Drug Sales by Application (2016-2021) & (K Doses)
Table 44. APAC Parkinsons Disease Drug Sales Market Share by Application (2016-2021)
Table 45. Europe Parkinsons Disease Drug Sales by Country (2016-2021) & (K Doses)
Table 46. Europe Parkinsons Disease Drug Sales Market Share by Country (2016-2021)
Table 47. Europe Parkinsons Disease Drug Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Parkinsons Disease Drug Revenue Market Share by Country (2016-2021)
Table 49. Europe Parkinsons Disease Drug Sales by Type (2016-2021) & (K Doses)
Table 50. Europe Parkinsons Disease Drug Sales Market Share by Type (2016-2021)
Table 51. Europe Parkinsons Disease Drug Sales by Application (2016-2021) & (K Doses)
Table 52. Europe Parkinsons Disease Drug Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Parkinsons Disease Drug Sales by Country (2016-2021) & (K Doses)
Table 54. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Parkinsons Disease Drug Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Parkinsons Disease Drug Sales by Type (2016-2021) & (K Doses)
Table 58. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Parkinsons Disease Drug Sales by Application (2016-2021) & (K Doses)
Table 60. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Parkinsons Disease Drug
Table 62. Key Application and Potential Industries of Parkinsons Disease Drug
Table 63. Key Challenges of Parkinsons Disease Drug
Table 64. Key Trends of Parkinsons Disease Drug
Table 65. Parkinsons Disease Drug Distributors List
Table 66. Parkinsons Disease Drug Customer List
Table 67. Global Parkinsons Disease Drug Sales Forecast by Region (2021-2026) & (K Doses)
Table 68. Global Parkinsons Disease Drug Consumption Market Forecast by Region
Table 69. Global Parkinsons Disease Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Parkinsons Disease Drug Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Parkinsons Disease Drug Sales Forecast by Country (2021-2026) & (K Doses)
Table 72. Americas Parkinsons Disease Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Parkinsons Disease Drug Sales Forecast by Region (2021-2026) & (K Doses)
Table 74. APAC Parkinsons Disease Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Parkinsons Disease Drug Sales Forecast by Country (2021-2026) & (K Doses)
Table 76. Europe Parkinsons Disease Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Parkinsons Disease Drug Sales Forecast by Country (2021-2026) & (K Doses)
Table 78. Middle East & Africa Parkinsons Disease Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Parkinsons Disease Drug Sales Forecast by Type (2021-2026) & (K Doses)
Table 80. Global Parkinsons Disease Drug Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Parkinsons Disease Drug Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Parkinsons Disease Drug Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Parkinsons Disease Drug Sales Forecast by Application (2021-2026) & (K Doses)
Table 84. Global Parkinsons Disease Drug Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Parkinsons Disease Drug Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Parkinsons Disease Drug Revenue Market Share Forecast by Application (2021-2026)
Table 87. Teva Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Teva Parkinsons Disease Drug Product Offered
Table 89. Teva Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 90. Teva Main Business
Table 91. Teva Latest Developments
Table 92. Novartis AG Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis AG Parkinsons Disease Drug Product Offered
Table 94. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 95. Novartis AG Main Business
Table 96. Novartis AG Latest Developments
Table 97. GSK Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Parkinsons Disease Drug Product Offered
Table 99. GSK Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. AbbVie Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. AbbVie Parkinsons Disease Drug Product Offered
Table 104. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 105. AbbVie Main Business
Table 106. AbbVie Latest Developments
Table 107. Merck Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Parkinsons Disease Drug Product Offered
Table 109. Merck Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 110. Merck Main Business
Table 111. Merck Latest Developments
Table 112. Boehringer Ingelheim Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Boehringer Ingelheim Parkinsons Disease Drug Product Offered
Table 114. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 115. Boehringer Ingelheim Main Business
Table 116. Boehringer Ingelheim Latest Developments
Table 117. Impax Laboratories Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Impax Laboratories Parkinsons Disease Drug Product Offered
Table 119. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 120. Impax Laboratories Main Business
Table 121. Impax Laboratories Latest Developments
Table 122. Lundbeck Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Lundbeck Parkinsons Disease Drug Product Offered
Table 124. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 125. Lundbeck Main Business
Table 126. Lundbeck Latest Developments
Table 127. Sun Pharma Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Sun Pharma Parkinsons Disease Drug Product Offered
Table 129. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 130. Sun Pharma Main Business
Table 131. Sun Pharma Latest Developments
Table 132. Wockhardt Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Wockhardt Parkinsons Disease Drug Product Offered
Table 134. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 135. Wockhardt Main Business
Table 136. Wockhardt Latest Developments
Table 137. UCB Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. UCB Parkinsons Disease Drug Product Offered
Table 139. UCB Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 140. UCB Main Business
Table 141. UCB Latest Developments
Table 142. Bausch Health Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Bausch Health Parkinsons Disease Drug Product Offered
Table 144. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 145. Bausch Health Main Business
Table 146. Bausch Health Latest Developments
Table 147. Acadia Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Acadia Parkinsons Disease Drug Product Offered
Table 149. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 150. Acadia Main Business
Table 151. Acadia Latest Developments
List of Figures
Figure 1. Picture of Parkinsons Disease Drug
Figure 2. Parkinsons Disease Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Parkinsons Disease Drug Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Parkinsons Disease Drug Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Parkinsons Disease Drug Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Carbidopa/Levodopa
Figure 10. Product Picture of Dopamine Receptor Agonists
Figure 11. Product Picture of MAO-Inhibitors
Figure 12. Global Parkinsons Disease Drug Sales Market Share by Type in 2020
Figure 13. Global Parkinsons Disease Drug Revenue Market Share by Type (2016-2021)
Figure 14. Parkinsons Disease Drug Consumed in Hospital
Figure 15. Global Parkinsons Disease Drug Market: Hospital (2016-2021) & (K Doses)
Figure 16. Parkinsons Disease Drug Consumed in Clinics
Figure 17. Global Parkinsons Disease Drug Market: Clinics (2016-2021) & (K Doses)
Figure 18. Parkinsons Disease Drug Consumed in Other
Figure 19. Global Parkinsons Disease Drug Market: Other (2016-2021) & (K Doses)
Figure 20. Global Parkinsons Disease Drug Sales Market Share by Application (2016-2021)
Figure 21. Global Parkinsons Disease Drug Revenue Market Share by Application in 2020
Figure 22. Parkinsons Disease Drug Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Parkinsons Disease Drug Revenue Market Share by Company in 2020
Figure 24. Global Parkinsons Disease Drug Sales Market Share by Regions (2016-2021)
Figure 25. Global Parkinsons Disease Drug Revenue Market Share by Region in 2020
Figure 26. Americas Parkinsons Disease Drug Sales 2016-2021 (K Doses)
Figure 27. Americas Parkinsons Disease Drug Revenue 2016-2021 ($ Millions)
Figure 28. APAC Parkinsons Disease Drug Sales 2016-2021 (K Doses)
Figure 29. APAC Parkinsons Disease Drug Revenue 2016-2021 ($ Millions)
Figure 30. Europe Parkinsons Disease Drug Sales 2016-2021 (K Doses)
Figure 31. Europe Parkinsons Disease Drug Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Parkinsons Disease Drug Sales 2016-2021 (K Doses)
Figure 33. Middle East & Africa Parkinsons Disease Drug Revenue 2016-2021 ($ Millions)
Figure 34. Americas Parkinsons Disease Drug Sales Market Share by Country in 2020
Figure 35. Americas Parkinsons Disease Drug Revenue Market Share by Country in 2020
Figure 36. Americas Parkinsons Disease Drug Sales Market Share by Type in 2020
Figure 37. Americas Parkinsons Disease Drug Sales Market Share by Application in 2020
Figure 38. United States Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Parkinsons Disease Drug Sales Market Share by Region in 2020
Figure 43. APAC Parkinsons Disease Drug Revenue Market Share by Regions in 2020
Figure 44. APAC Parkinsons Disease Drug Sales Market Share by Type in 2020
Figure 45. APAC Parkinsons Disease Drug Sales Market Share by Application in 2020
Figure 46. China Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Parkinsons Disease Drug Sales Market Share by Country in 2020
Figure 53. Europe Parkinsons Disease Drug Revenue Market Share by Country in 2020
Figure 54. Europe Parkinsons Disease Drug Sales Market Share by Type in 2020
Figure 55. Europe Parkinsons Disease Drug Sales Market Share by Application in 2020
Figure 56. Germany Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Application in 2020
Figure 65. Egypt Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Parkinsons Disease Drug Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs